drugset / Trial / NCT01363284

Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients

NCT01363284

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to identify, prior to prescribing, which neuropathic pain patients will benefit from duloxetine more specific the investigators aims are to: * Verify whether presence of chronic pain alters the pain modulation mechanisms, such as DNIC (diffuse noxious inhibitory control) and TS (temporal summation). * Investigate whether anti-neuropathic medications such as duloxetine indeed change the pain modulation profile, and whether this profile change is associated with a reduction of clinical pain.

Timeline

Start
2010-06
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg